Significant differences in access to tests and treatments for multiple myeloma between public and private systems in Latin America. Results of a Latin American survey. GELAMM (Grupo de Estudio Latino Americano de Mieloma Múltiple)
Riva, EloÃsa, Schütz, N., Peña, C., Ruiz-Argüelles, G., Hopkins, C. Rojas, Bove, V., Villano, F., Andino, L., Suárez, L., MartÃnez, H., Navarro, J., López-Vidal, H., Da Costa, O., Pineda, M. RoJournal:
Annals of Hematology
DOI:
10.1007/s00277-020-03983-x
Date:
March, 2020
File:
PDF, 272 KB
2020
File converter
More search results
More benefits 
